Bloomberg :press: on Nostr: GSK, iTeos Lung Cancer Data Set to Reignite Hope for Drug Class Early data from GSK ...
GSK, iTeos Lung Cancer Data Set to Reignite Hope for Drug Class
Early data from GSK Plc and iTeos Therapeutics’ mid-stage trial of a lung cancer medicine looks set to renew cautious optimism around a class of immunotherapy drugs that has suffered a series of setbacks. #press
https://www.bloomberg.com/news/articles/2024-09-14/gsk-iteos-lung-cancer-data-set-to-reignite-hope-for-drug-class?utm_source=press.coop
Early data from GSK Plc and iTeos Therapeutics’ mid-stage trial of a lung cancer medicine looks set to renew cautious optimism around a class of immunotherapy drugs that has suffered a series of setbacks. #press
https://www.bloomberg.com/news/articles/2024-09-14/gsk-iteos-lung-cancer-data-set-to-reignite-hope-for-drug-class?utm_source=press.coop